LEXICON PHARMACEUTICALS INCLXRX
ASignal's systematic analysis rates LXRX as Bearish.
Reflects the latest available analysis · analyzed Sep 20, 2026
The case on LXRX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI indicates oversold conditions (26.92), potentially signaling near-term reversal
- Strong liquidity position with current ratio of 13.37x and quick ratio of 13.07x
- Low debt-to-equity ratio of 0.34x, indicating conservative capital structure
- Gross margin remains high at 86.02%, suggesting pricing power or efficient cost control
- Negative MACD histogram and price momentum indicating ongoing downtrend
- Revenue growth YoY at -97.60%, signaling severe top-line contraction
- Negative free cash flow of $-44.77M and operating cash flow of $-64.99M
- Negative profit and operating margins, with ROE of -40.21% indicating poor capital efficiency
- Forward P/E and EV/EBITDA are negative, reflecting unprofitable earnings base
See the full verdict on LXRX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes LXRX
Most investors never get a second opinion, let alone several. ASignal runs LXRX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.